Header cover image

Taiwanese (TAIEX) Life Sciences Industry Analysis

UpdatedMay 29, 2024
DataAggregated Company Financials
Companies9
  • 7D-0.5%
  • 3M-9.0%
  • 1Y-26.6%
  • YTD-15.1%

Over the last 7 days, the Life Sciences industry has dropped 1.6%, driven by EirGenix declining 1.7%. However, the industry is down 28% over the past year. Earnings are forecast to grow by 128% annually.

Industry Valuation and Performance

Has the Taiwanese Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 29 May 2024NT$40.0bNT$2.1b-NT$797,765,000.0032.4x-50.2x18.7x
Fri, 26 Apr 2024NT$39.3bNT$2.1b-NT$914,899,000.0032.9x-42.9x18.5x
Sun, 24 Mar 2024NT$40.2bNT$2.1b-NT$606,177,000.0031.3x-66.4x19.4x
Tue, 20 Feb 2024NT$44.3bNT$2.1b-NT$610,218,000.0033.1x-72.5x21.3x
Thu, 18 Jan 2024NT$44.6bNT$2.1b-NT$610,218,000.0032.7x-73.1x21.5x
Sat, 16 Dec 2023NT$48.6bNT$2.1b-NT$610,218,000.0032.8x-79.7x23.4x
Mon, 13 Nov 2023NT$48.2bNT$2.2b-NT$497,769,000.0031.7x-96.9x21.7x
Wed, 11 Oct 2023NT$48.3bNT$2.2b-NT$497,769,000.0031.4x-97.1x21.7x
Fri, 08 Sep 2023NT$43.1bNT$2.2b-NT$497,769,000.0031.6x-86.6x19.4x
Sun, 06 Aug 2023NT$47.1bNT$2.4b-NT$281,587,000.0044.7x-167.4x19.3x
Tue, 04 Jul 2023NT$49.6bNT$2.5b-NT$274,767,000.0043.3x-180.4x20.2x
Thu, 01 Jun 2023NT$50.6bNT$2.5b-NT$262,467,000.0043.4x-192.9x20.4x
Sat, 29 Apr 2023NT$46.8bNT$2.7b-NT$29,017,000.0023.7x-1612.6x17.6x
Mon, 27 Mar 2023NT$49.4bNT$2.7b-NT$29,761,000.0024.7x-1661.2x18.6x
Wed, 22 Feb 2023NT$51.1bNT$2.7bNT$85.3m21.6x599.8x19.1x
Fri, 20 Jan 2023NT$45.3bNT$2.7bNT$85.3m19.1x531.4x16.9x
Sun, 18 Dec 2022NT$50.4bNT$2.7bNT$139.5m18.7x361.7x18.9x
Tue, 15 Nov 2022NT$47.6bNT$2.7bNT$139.5m18.9x341.5x17.8x
Thu, 13 Oct 2022NT$46.3bNT$3.0bNT$482.8m24x95.9x15.5x
Sat, 10 Sep 2022NT$50.3bNT$3.0bNT$482.8m27x104.2x16.8x
Mon, 08 Aug 2022NT$39.6bNT$3.1bNT$325.5m37.7x121.6x12.9x
Wed, 06 Jul 2022NT$37.9bNT$3.1bNT$325.1m36x116.5x12.3x
Fri, 03 Jun 2022NT$30.7bNT$3.1bNT$325.1m36.3x94.4x10x
Sun, 01 May 2022NT$34.5bNT$3.2bNT$164.4m28.1x209.7x10.8x
Tue, 29 Mar 2022NT$32.8bNT$3.0b-NT$134,053,000.0027.3x-244.5x10.9x
Thu, 24 Feb 2022NT$36.7bNT$3.0b-NT$120,147,000.0034.5x-305.4x12x
Sat, 22 Jan 2022NT$36.5bNT$3.0b-NT$120,147,000.0035x-303.8x12x
Mon, 20 Dec 2021NT$38.5bNT$3.0b-NT$120,147,000.0037.4x-320.8x12.6x
Wed, 17 Nov 2021NT$30.4bNT$3.0b-NT$120,147,000.0035.2x-253x10x
Fri, 15 Oct 2021NT$29.9bNT$2.3b-NT$631,150,000.0031.3x-47.3x12.8x
Sun, 12 Sep 2021NT$35.0bNT$2.3b-NT$631,150,000.0031.8x-55.4x15x
Tue, 10 Aug 2021NT$37.6bNT$2.3b-NT$631,150,000.0032.4x-59.5x16.1x
Price to Earnings Ratio

-43.6x


Total Market Cap: NT$35.3bTotal Earnings: -NT$810,177,000.00Total Revenue: NT$2.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Life Sciences Industry Price to Earnings3Y Average -90.1x202220232024
Current Industry PE
  • Investors are optimistic on the Taiwanese Life Sciences industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 16.8x is lower than the industry's current PS ratio of 18.7x.
Past Earnings Growth
  • Losses for companies in the Life Sciences industry have remained mostly flat over the last three years and so have revenues.
  • This means that sales and the cost of doing business have remained relatively consistent over this period and subsequently, losses have remained steady.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market2.89%
Healthcare-0.91%
Life Sciences-0.51%
Clinical Research and Equipment-0.51%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6891 Locus CellNT$30.701.7%
+NT$100.0m		-30.7%PS7561.6x
6986 HeXun BiosciencesNT$71.501.6%
+NT$50.6m		n/an/a
7607 DuoGenic StemCellsNT$33.454.9%
+NT$47.4m		-25.7%n/a
6662 BioLASCO TaiwanNT$35.401.7%
+NT$15.4m		14.9%PE19.5x
6939 TFBS BioscienceNT$42.000.7%
+NT$10.4m		-40.2%n/a
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

6891

NT$30.70

Locus Cell

7D

1.7%

1Y

-30.7%

4133

NT$32.00

Abnova (Taiwan)

7D

-0.2%

1Y

-10.9%

6662

NT$35.40

BioLASCO Taiwan

7D

1.7%

1Y

14.9%

6589

NT$80.10

EirGenix

7D

-1.7%

1Y

-27.2%

6661

NT$22.50

Welgene BiotechLtd

7D

0.4%

1Y

-1.7%

6848

NT$16.05

RBC Bioscience

7D

0.3%

1Y

-2.1%

6939

NT$42.00

TFBS Bioscience

7D

0.7%

1Y

-40.2%

6986

NT$71.50

HeXun Biosciences

7D

1.6%

1Y

n/a

7607

NT$33.45

DuoGenic StemCells

7D

4.9%

1Y

-25.7%